TMDX - TransMedics Group, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
123.62 7.86 (6.36%) 0.15 (0.11%) -0.41 (-0.31%) -1.69 (-1.27%) 0.38 (0.31%) 8.09 (6.56%) 1.05 (0.86%) 1.87 (1.53%)

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Category: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Market Period: Market

Earnings & Ratios

Basic EPS:
1.03
Diluted EPS:
0.92
Basic P/E:
127.6505
Diluted P/E:
142.913
RSI(14) 1m:
35.64
VWAP:
131.41
RVol:

Events

Period Kind Movement Occurred At

Related News